Heterocyclic aminopyrimidine compound with adenosine receptor antagonist activity

The invention provides a heterocyclic aminopyrimidine compound with adenosine receptor antagonist activity. The heterocyclic aminopyrimidine compound with adenosine receptor antagonist activity comprises the compound, pharmaceutically acceptable salts of the compound, various isotopes, various isomers and various crystal structures and has a structure as shown in a general formula I. Serving as an effective antagonist of an adenosine receptor, the heterocyclic aminopyrimidine compound with adenosine receptor antagonist activity can be used for treating or preventing diseases caused by adenosine level disorder.